Over 20 year industry experience in drug research and development, ranging from discovery research through IND and NDA filings for oncology based therapies. Led preclinical development of Geron's telomerase activator program. Former VP, R&D for oncology and stem cell therapeutics at Cellerant Therapeutics.

Dr. Allsopp is a tenured professor at the John A. Burns School of Medicine of the University of Hawaii; his has over 20 years of experience in the field of telomere biology and stem cell biology. He has over 30 publications, including peer-reviewed articles and 3 books, and has worked in the laboratories of several leaders in the fields of telomere and stem cell biology, including stem cell pioneer Dr. Irving Weissman at Stanford University.

Dr. Lye has been in the biomedical research industry for fifteen years. He designed and managed clinical trials employing adult stem cells. Dr. Lye recieved his MD from the Wake Forest University School of Medicine and his MBA from Hawaii Pacific University. He is an assistant professor at the John A. Burns School of Medicine of the University of Hawaii, and the director of clinical research for Tissue Genesis, Inc.

Mr. Gerstenberger has 27 years of experience heading companies in the manufacturing, emerging biotech, and renewable energy fields.